FY2017 Suspension and Debarment Trends
Client Alert | less than 1 min read | 11.07.17
Crowell & Moring partner and former acting Air Force suspending and debarring official David Robbins published his annual examination of the government’s suspension and debarment statistics for the prior government fiscal year. The article, entitled Suspension and Debarment: FY 2017 By the Numbers ran in Law360 and may be accessed here. This article represents a deep dive into the raw suspension/debarment numbers listed on the System for Award Management and shows year-over-year trends not available on the government’s annual Interagency Suspension and Debarment Committee report. It covers agency-specific trends for excluding individuals, small businesses, traditional government contractors, and non-traditional government contractors.
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk
